ASCENTAGE PHARMA
LIVE

Serial Number

79339835

Owner

Jiangsu Ascentage Pharma Inc.

Attorney

Kathryn E. Smith

Filing Date

Mar 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ASCENTAGE PHARMA Trademark

Serial Number: 79339835 • Registration: 7209445

ASCENTAGE PHARMA is a trademark filed by Jiangsu Ascentage Pharma Inc. on March 14, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Jiangsu Ascentage Pharma Inc. (6 trademarks)

101 Room Of First Floor, Qb3 Buiding,

Entity Type: 99

ASCENTAGE PHARMA (SUZHOU) CO., LTD. (23 trademarks)

68 XINQING ROAD
SUZHOU 215000 , CN

Entity Type: 03

Trademark Details

Filing Date

March 14, 2022

Registration Date

November 7, 2023

Published for Opposition

August 22, 2023

Goods & Services

Scientific and medical research services, namely, studies for combined compound functional mechanism on animals; cancer research for medical purposes; pharmaceutical research and development, namely, early evaluation for implementation of the new drugs; pharmaceutical research; scientific surveys for medical purposes; chemical analysis services; research and analysis in the field of biochemistry; chemical research service; scientific and medical research services in the nature of chemical analysis assessment service; chemical research and analysis; scientific and medical research services in the nature of chemical synthesis assessment service; chemical analysis; chemistry consulting services; chemical research; cosmetic research; structural and functional analysis of genomes; stem cell research services; biotechnological research; blood analysis service; genetic screening for scientific purposes; biological cloning services; research and development of antibodies; genetic testing for scientific research purposes; bacteriological research and analysis; biomedical research; medical research; pharmaceutical drug development; medical laboratory service; development of pharmaceutical preparations and pharmaceuticals; medical research service; biological research and analysis; bacteriological research; biological research; scientific and medical research, namely conducting clinical trials for others; computer programming of medical aspects; scientific and technical services, namely, testing and evaluation of pharmaceuticals; pharmaceutical research

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 23, 2026 NREP
CHANGE OF OWNER RECEIVED FROM IB
Nov 7, 2025 CHLD
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 21, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 21, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 21, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 21, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 21, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 21, 2025 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 4, 2024 FINO
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 26, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 26, 2024 REAP
FINAL DISPOSITION NOTICE SENT TO IB
Feb 8, 2024 FICS
FINAL DISPOSITION PROCESSED
Feb 8, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 7, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 7, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 7, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 31, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 11, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 11, 2023 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 22, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 22, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Aug 21, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 2, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 2, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 2, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 17, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 12, 2023 TROA
REFUSAL PROCESSED BY IB
Mar 15, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 22, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 22, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 27, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 26, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 25, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
May 10, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 5, 2022 REPR